Company: NIVFW
Filing Date: 2025-06-03
Form Type: 424B3
Source: 0001213900-25-050825
Chunk: 156

Company: NewGenIvf Group Ltd
Filing Date: 2025-06-03
Form: 424B3
Chunk 156
---

the sale of all of the shares offered by the Selling Securityholder pursuant to this prospectus.

The Company may require the
Selling Securityholder to suspend the sales of the Resale Shares offered by this prospectus upon the occurrence of any event that makes
any statement in this prospectus or the Registration Statement untrue in any material respect or that requires the changing of statements
in these documents in order to make statements in those documents not misleading.

Under the terms of the Remaining Additional
Notes and the Warrants, Selling Securityholder may not convert the Remaining Additional Notes or exercise the Warrants to the extent
(but only to the extent) such Selling Remaining Additional or any of its affiliates would beneficially own a number of shares of our
ordinary shares which would exceed 9.99% of the outstanding shares of the Company (the “Maximum Percentage”). The number
of shares in the second column reflects these limitations. The Selling Securityholder may sell all, some or none of their shares in this
offering. See “Plan of Distribution.”

<div align='center'>91</div>

| Name of Selling Securityholders |     | Ordinary     
 Shares       
 Beneficially 
 Owned        
 Prior to     
 Offering(1)  |         |    |     | Percentage of                      
 Ordinary Shares Beneficially Owned 
 Prior to                           
 Offering(1)                        |      |   |     | Maximum     
 Number of   
 Ordinary    
 Shares      
 to be       
 Sold        
 Pursuant to 
 this        
 Prospectus  |            |    |     | Ordinary                  
 Shares Beneficially Owned 
 Immediately               
 After Sale of             
 Maximum                   
 Number of Shares          
 in this                   
 Offering(2)               |   |     | Percentage of                                  
 Ordinary Shares Beneficially Owned Immediately 
 After                                          
 Sale of                                        
 Maximum                                        
 Number of Shares                               
 in this                                        
 Offering(1)(2)                                 |   |   |
| JAK                             
 Opportunities VI LLC (3)        |     |              | 104,978 | -7 |     |                                    | 9.99 | % |     |             | 12,000,000 | -8 |     |                           | 0 |     |                                                | 0 | % |
| White                           
 Lion Capital LLC (4)            |     |              |       0 |    |     |                                    |      |   |     |             | 10,000,000 |    |     |                           | 0 |     |                                                | 0 | % |
| Genetics                        
 & IVF Institute